Traders should note this is not new financial data but a reorganization of previously reported revenue for better comparability. The disclosure provides no new guidance or material financial information that would impact investment decisions.
How the stock moved after the report
NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · Apr 14 $70.54entry
- T+1 · 7mo ago +0.27%α −0.51% · $70.73
- T+5 · 7mo ago −3.79%α −5.18% · $67.87
- T+20 · 6mo ago −14.50%α −20.80% · $60.31
- T+60 · 4mo ago +1.30%α −7.22% · $71.46
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Merit Medical Systems disclosed historical revenue data disaggregated by its new foundational and therapeutic product categories for 2022-2025 and quarterly data for 2024-2025 to aid period-over-period comparisons. This is a routine disclosure of previously reported financials, not a revision or restatement.
Key Facts
- Provided historical revenue by product category (Foundational and Therapeutic) for years 2022-2025
- Disclosed quarterly revenue data for 2024 and 2025 by product category
- Provided supplemental revenue data by product platform for years 2022-2025
- Company stated this information is for comparison purposes and does not constitute a revision of previously reported financials
Financial Impact
No new financial impact - this is disclosure of previously reported historical data for comparative purposes
Risk Factors
- None - this is a routine disclosure of historical data
- Investors should not interpret this as new financial information or guidance
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0000856982-26-000020 |
| Document: 0000856982-26-000020-index-headers.html | 0000856982-26-000020 |
| Document: 0000856982-26-000020-index.html | 0000856982-26-000020 |
| Document: 0000856982-26-000020.txt | 0000856982-26-000020 |
Track record
12 reports on MMSI
3 of 4 bullish or bearish reports moved the stock their way by T+60. Best: +37.91% at T+60 after the May 5, 2026 report. 4 of 5 went positive at some point.
Filters
- Nov 5, 202611d ago Press Release Neutral 3/10 Entry $89.62 Now $86.35 −3.65% settles Feb 3
- Oct 29, 202618d ago 8-K Bullish 6/10 No price data
- Oct 29, 202618d ago Press Release Bullish 6/10 Entry $86.24 Now $86.35 +0.13% settles Jan 28
- Oct 29, 202618d ago Press Release Neutral 4/10 Entry $86.24 Now $86.35 +0.13% settles Jan 28
- Oct 27, 202620d ago Institutional Cluster Mixed 4/10 Entry $92.21 Now $86.35 −6.36% settles Jan 26
- Jul 2, 202619w ago Press Release Neutral 1/10 Entry $71.09 to $87.00 Now $86.35 +21.47% ▲ +22.38% +18.81% vs SPY
- May 5, 202628w ago Insider Cluster Neutral 3/10 Entry $60.44 to $83.35 Now $86.35 +42.87% ▲ +37.91% +35.17% vs SPY
- May 5, 202628w ago Insider Cluster Bullish 6/10 Entry $60.44 to $83.35 Now $86.35 +42.87% ▲ +37.91% +35.17% vs SPY
- Apr 30, 202628w ago Press Release Bullish 7/10 Entry $62.01 to $78.29 Now $86.35 +39.25% ▲ +26.25% +23.18% vs SPY
- Apr 16, 202630w ago Court Ruling Bullish 6/10 Entry $70.10 to $73.26 Now $86.35 +23.18% ▲ +4.51% −2.54% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers